Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States - authors’ reply
dc.contributor.author | Gawrieh, Samer | |
dc.contributor.author | Sulkowski, Mark | |
dc.contributor.author | Chalasani, Naga | |
dc.contributor.author | Loomba, Rohit | |
dc.contributor.department | Medicine, School of Medicine | |
dc.date.accessioned | 2025-04-22T14:42:33Z | |
dc.date.available | 2025-04-22T14:42:33Z | |
dc.date.issued | 2024 | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Gawrieh S, Sulkowski M, Chalasani N, Loomba R. Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' reply. Aliment Pharmacol Ther. 2024;59(6):791. doi:10.1111/apt.17886 | |
dc.identifier.uri | https://hdl.handle.net/1805/47323 | |
dc.language.iso | en_US | |
dc.publisher | Wiley | |
dc.relation.isversionof | 10.1111/apt.17886 | |
dc.relation.journal | Alimentary Pharmacology & Therapeutics | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Fatty liver | |
dc.subject | HIV infections | |
dc.subject | Liver cirrhosis | |
dc.title | Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States - authors’ reply | |
dc.type | Article |